About

Management

Members of theBoard of Directors
Audit & SupervisoryBoard Member
Corporate Officers

Members of the Board of Directors

Gyo Sagara: Representative Director, Chairman of the Board and Chief Executive Officer

summary

April	1983	Joined the Company
April	2006	Executive Director, General Administration and Senior Director, Corporate Management
June	2006	Member of the Board of Directors
April	2007	Executive Director, Corporate Management
November	2007	Executive Director, Sales and Marketing
December	2007	Managing Member of the Board of Directors
February	2008	Member of the Board of Directors, Vice President
April	2008	Executive Director, Corporate Management
June	2008	Vice President and Representative Director
September	2008	President, Representative Director & CEO
April	2024	Representative Director, Chairman of the Board & CEO (to date)

Toichi Takino, Ph.D.: Representative Director, President and Chief Operating Officer

summary

April	1995	Joined the Company
April	2006	Senior Director, International Business
March	2007	Senior Director, Business Development
July	2009	Vice President, ONO PHARMA USA INC.
June	2011	Corporate Officer
April	2012	Executive Director, Corporate Development & Strategy
October	2018	Executive Director, Discovery and Research Division
April	2019	Executive Director, Discovery & Research
June	2019	Corporate Executive Officer
June	2020	Member of the Board of Directors, Executive Officer
June	2021	Member of the Board of Directors, Senior Executive Officer
April	2024	Representative Director, President & COO (to date)

Toshihiro Tsujinaka: Representative Director, Executive Vice President / Executive Director, Corporate Strategy & Planning, HR Division, Sustainability Promotion

summary

April	1988	Joined the Company
June	2004	Senior Director, Koshinetsu Branch Sales Division
November	2007	Senior Director, Sales Operations
October	2012	Senior Director, Sendai Branch Sales Division
October	2015	Senior Director, Oncology Planning &Promotion
April	2016	Division Director, Oncology Business Division
June	2016	Corporate Officer
October	2018	Executive Director, Corporate Strategy & Planning
June	2019	Corporate Executive Officer
June	2020	Member of the Board of Directors, Executive Officer
June	2021	Member of the Board of Directors, Senior Executive Officer
June	2023	Executive Director, Corporate Strategy & Sustainability Promotion
April	2024	Representative Director, Executive Vice President (to date)
October	2024	Executive Director, Corporate Strategy & Planning, HR Division, Sustainability Promotion (to date)

Masao Nomura: Member of the Board of Directors, Outside Director

summary

March	1972	Joined lwatani Corporation
June	2007	Director, Executive Officer, lwatani Corporation
April	2009	Executive Director, Executive Officer, lwatani Corporation
April	2010	Senior Executive Director, Executive Officer, lwatani Corporation
June	2012	President, Representative Director, Executive Officer, lwatani Corporation
April	2017	Director, Senior Adviser to the Board, Executive Officer, lwatani Corporation
June	2017	Senior Adviser to the Board, lwatani Corporation
June	2018	Member of the Board of Directors, Outside Director (to date)
June	2019	Outside Director, Keihanshin Building Co., Ltd. (to date)
June	2020	Outside Director, NEW COSMOS ELECTRIC CO., LTD.
July	2022	Advisor, lwatani Corporation (to date)

＜Status or important concurrent holding of positions＞
Advisor, lwatani Corporation
Outside Director, Keihanshin Building Co., Ltd.

Akiko Okuno: Member of the Board of Directors, Outside Director

summary

April	2002	Associate Professor, Faculty of Economics, Osaka University of Economics and Law
April	2004	Associate Professor, Faculty of Business Administration, Tezukayama University
April	2010	Professor, Faculty of Business Administration, Tezukayama University
April	2012	Professor, Faculty of Business Administration, KONAN UNIVERSITY (to date)
June	2020	Member of the Board of Directors, Outside Director (to date)

＜Status or important concurrent holding of positions＞
Professor, Faculty of Business Administration, KONAN UNIVERSITY

Shusaku Nagae: Member of the Board of Directors, Outside Director

summary

April	1972	Joined Matsushita Electric Works, Ltd.
December	2004	Managing Executive Officer, Matsushita Electric Works, Ltd.
June	2007	Managing Director, Matsushita Electric Works, Ltd.
June	2010	Representative Director, President, Panasonic Electric Works Co., Ltd.
June	2012	Representative Director, Executive Vice President, Panasonic Corporation (currently Panasonic Holdings Corporation)
June	2013	Representative Director, Chairman of the Board, Panasonic Corporation
June	2017	Director, Chairman of the Board, Panasonic Corporation
June	2021	Member of the Board of Directors, Outside Director (to date)
June	2021	Special Corporate Advisor, Panasonic Corporation (currently Panasonic Holdings Corporation)(to date)
March	2023	Outside Audit & Supervisory Board Member, Nikkei Inc. (to date)
March	2024	Outside Director, Poppins Corporation (to date)

＜Status or important concurrent holding of positions＞
Special Corporate Advisor, Panasonic Holdings Corporation
Outside Audit & Supervisory Board Member, Nikkei Inc.
Outside Director, Poppins Corporation

Audit & Supervisory Board Member

Hironobu Tanisaka: Audit & Supervisory Board Member

summary

April	1984	Joined the Company
August	2007	Senior Director, Legal Department
January	2018	Senior Director, Business Audit Department
June	2021	Full-time Audit & Supervisory Board Member (to date)

Kiyoaki Idemitsu: Audit & Supervisory Board Member

summary

April	1987	Joined the Company
December	2000	President, ONO PHARMA UK LTD.
January	2008	Senior Director, Discovery Research Alliance
January	2010	Senior Director, Global Business Department &Licensing
April	2012	Division Director, Discovery Research Alliance Division
October	2013	Senior Director, Nivolumab Strategic Planning
April	2017	Division Director, Medical Affairs
October	2018	Corporate Officer
October	2018	Executive Director, Clinical Development
June	2020	Corporate Executive Officer
June	2021	Member of the Board of Directors, Executive Officer
April	2024	Executive Director, Clinical Development, Global Clinical Development Management Unit
May	2024	Chief Officer, Clinical Development
June	2024	Full-time Audit & Supervisory Board Member (to date)

Yasuo Hishiyama: Outside Audit & Supervisory Board Member

summary

April	1999	Appointed as a judge (served at Sendai District Court,Saitama District Court and Osaka Family Court)
April	2006	Registered as an attorney at law (Dai-lchi Tokyo Bar Association)
April	2006	Joined TANABE & PARTNERS (to date)
January	2010	Member or appraisal committee (Land Lease Non-Contentious Cases) at Tokyo District Court (to date)
June	2016	Outside Audit & Supervisory Board Member (to date)
June	2023	Outside Audit & Supervisory Board Member, Yoshimoto Pole Co., Ltd. (to date)

＜Status or important concurrent holding of positions＞
Partner Attorney at Law, TANABE & PARTNERS
Outside Audit & Supervisory Board Member, Yoshimoto Pole Co., Ltd.
Member or appraisal committee (Land Lease Non-Contentious Cases) at Tokyo District Court

Akiko Tanabe: Outside Audit & Supervisory Board Member

summary

October	1993	Joined Century Audit Corporation (Present: Ernst & Young ShinNihon LLC)
May	1997	Registered as Certified Public Accountant
January	2012	Established Akiko Tanabe CPA office (to date)
June	2015	Outside Director, OIE SANGYO CO.,LTD. (to date)
July	2019	Partner of Midosuji Audit Corporation (to date)
April	2020	Provisional Outside Audit & Supervisory Board Member
June	2020	Outside Audit & Supervisory Board Member (to date)

＜Status or important concurrent holding of positions＞
Representative, Akiko Tanabe CPA office
Outside Director, OIE SANGYO CO., LTD.
Partner of Midosuji Audit Corporation

Corporate Officers

Akira Takada: Corporate Executive Officer / Executive Director, CMC & Production, Production Technology Management

Satoshi Takahagi: Corporate Executive Officer / Executive Director, Sales and Marketing, Oncology Business Division

Hiromu Habashita, Ph.D.: Corporate Officer / Deputy Executive Director, Discovery & Research

Shinji Takai, M.D., Ph.D.: Corporate Officer / Head of Medical Affairs

Masaki Itoh: Corporate Officer / Division Director, Corporate Strategy & Planning, Business Management Division, Business Management Department ／ President, Ono Digital health Investment, GK.

Tatsuya Okamoto: Corporate Officer / Executive Director, Clinical Development, Global Clinical Development Management Unit, Oncology Clinical Development Division

Masayuki Tanigawa: Corporate Officer / Executive Director, Corporate Development ＆ Strategy, License

Takehiro Yamada: Corporate Officer / Senior Director, Risk & Compliance Management Department

Hirokazu Kitada: Corporate Officer / Division Director, Primary Care Business Division

Yasushi Hirota: Corporate Officer / Executive Director, Corporate RegulatoryCompliance, Safety and Quality Assurance

Seishi Katsumata: Corporate Officer / Executive Director, Discovery & Research, Research Project Management Division

Kunihiko Ito: Corporate Officer / President/CEO, Ono Pharma USA, Inc.